Companies / Massachusetts / Immuneering

· rebuilt nightly from public records

Signal Sheet

Selling to Immuneering? Who to reach and why now

Headquartered in Cambridge, Massachusetts, Immuneering is a publicly listed pharmaceutical preparations company. It raised $25M in Aug 2025 and its filings name 6 officers. Everything below links to the record it came from.

Listed company · Pharmaceutical Preparations · Massachusetts

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerBenjamin J. ZeskindSEC filing, Aug 2025Named officer in the filing; part of the buying group
Chief Technology OfficerRobert J. CarpenterSEC filing, Aug 2025Technology and tooling decisions
Chief Technology OfficerPeter FeinbergSEC filing, Aug 2025Technology and tooling decisions
Chief Technology OfficerDiana F. HausmanSEC filing, Aug 2025Technology and tooling decisions
Chief Technology OfficerLaurie B. KeatingSEC filing, Aug 2025Technology and tooling decisions
Chief Technology OfficerThomas J. SchallSEC filing, Aug 2025Technology and tooling decisions
For sellersWhy Immuneering is worth a call this quarterBuy Window: open · new leadership Nov 2026
Nov 9Nov 2026

New leadership

Officer or director change

New leadership
$25M

Raised

Equity raise reported to the SEC, Aug 2025. Money arrives before the spending plan does.

Capital
6officers

Named in filings

Each with a title and the filing that names them, so the first call goes to the right desk.

People
Track Immuneering with a free trial →Get the next signal the day it is filed or posted.
Email me the next Immuneering signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
Nov 9, 2026Officer or director changeNew leadershipSEC filing
Aug 26, 2025Raised $25M in equity from 9 investorsCapitalSEC filing

Email format

Immuneering uses [email protected]. For someone named Jane Doe that is [email protected]. Lakewave confirmed this pattern. A company pattern is the common shape, not a guarantee for any one person. Many companies run more than one format at once: founders, early hires, acquired teams and regional offices often differ. So Lakewave does not apply one pattern across a whole company. It verifies the address for each person on its own, and a free trial gives you the email that reaches each person above.
Get verified addresses, free →

Reach Immuneering with emails that land

Lakewave finds the right people at Immuneering, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Immuneering with a free trial →

About Immuneering

HeadquartersCambridge, Massachusetts, per the filing address
Industry groupPharmaceutical Preparations
OwnershipListed company
Raise history$25M (Aug 2025)
Lakewave Rising21 · 1 kinds of evidence · rank in Massachusetts after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Alnylam Pharmaceuticals · 35Apnimed · 35Climb Bio · 18Cue Biopharma · 4Enveric Biosciences · 2Kala BIO · 1See all 6 with a free trial →

Questions people ask

Did Immuneering raise funding in 2025?

Yes. Immuneering reported a $25M equity raise to the SEC on Aug 26, 2025 with 9 investors.

Who runs Immuneering?

The company's SEC filing, Aug 2025 names Benjamin J. Zeskind (Executive Officer) among its officers.

Where is Immuneering headquartered?

Cambridge, Massachusetts, per the address on its SEC filing.

What is Immuneering's email format?

Immuneering uses [email protected]. For someone named Jane Doe that is [email protected]. Lakewave confirmed this pattern.

Does everyone at Immuneering use the same email format?

Not always. Many companies run more than one format at once: founders, early hires, acquired teams and regional offices often differ. That is why Lakewave does not apply one pattern across a whole company. It verifies the address for each person on its own, so you are not relying on a guessed pattern.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.